Cases & Deals

InSite Vision monetizes patent-related royalty stream

Client(s) InSite Vision Incorporated

Jones Day advised InSite Vision Incorporated, a developer of novel ophthalmic products designed to treat a growing range of common eye problems, in connection with the monetization of a patent-related royalty stream from future sales of Besivance® (besifloxacin opthalmic suspension), which is marketed globally by Bausch & Lomb for the treatment of bacterial conjunctivitis.